Drug Shortage Report for TEVA-SUMATRIPTAN
| Report ID | 151381 |
| Drug Identification Number | 02239367 |
| Brand name | TEVA-SUMATRIPTAN |
| Common or Proper name | TEVA-SUMATRIPTAN 100MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SUMATRIPTAN |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | PP6 |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-12-14 |
| Estimated end date | 2022-11-20 |
| Actual end date | 2022-12-01 |
| Shortage status | Resolved |
| Updated date | 2022-12-02 |
| Company comments | Item is on Suspended Supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2022-12-02 | English | Compare |
| v25 | 2022-12-01 | French | Compare |
| v24 | 2022-12-01 | English | Compare |
| v23 | 2022-12-01 | English | Compare |
| v22 | 2022-10-28 | French | Compare |
| v21 | 2022-10-28 | English | Compare |
| v20 | 2022-10-17 | French | Compare |
| v19 | 2022-10-17 | English | Compare |
| v18 | 2022-09-30 | French | Compare |
| v17 | 2022-09-30 | English | Compare |
| v16 | 2022-08-18 | French | Compare |
| v15 | 2022-08-18 | English | Compare |
| v14 | 2022-04-28 | French | Compare |
| v13 | 2022-04-28 | English | Compare |
| v12 | 2022-04-21 | French | Compare |
| v11 | 2022-04-21 | English | Compare |
| v10 | 2022-03-17 | French | Compare |
| v9 | 2022-03-17 | English | Compare |
| v8 | 2022-03-09 | French | Compare |
| v7 | 2022-03-09 | English | Compare |